DuPont de Nemours Inc vs Smith & Nephew plc — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.51B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: DuPont de Nemours Inc is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| DD | SNN | |
|---|---|---|
Market Cap | $19.51B | $12.54B |
Sector | Basic Materials | Health |
52-Week High | $154.59 | $38.70 |
52-Week Low | $90.24 | $28.73 |
Enterprise Value | $20.90B | $15.57B |
Dividend Yield | 1.66% | 2.65% |
Trailing returns across standard periods
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →